When Laura Indolfi set out to launch a biotech in Boston, she had an idea — and little else. She had never run a company before. She had no practical experience in fundraising.
But she was undeterred. In 2014 she founded PanTher Therapeutics, with the goal of turning a postdoctoral side project into a bona-fide drug delivery company.
About the Author Reprints
I’m surprised that the writer didn’t mention that the Dyne CEOs kids play on the same teams with an Atlas partners – and that the Atlas partner holds ‘Wellesley Only’ biotech meetups once a month.
Social connections first, science second
or, that’s why many biotech startups don’t go anywhere, and most are selling revolutionary hot air